LingVo.club
📖+20 XP
🎧+15 XP
+25 XP
Study: Common Sleep Habits Linked to Brain Aging (Level A2) — person in blue denim jeans lying on bed

Study: Common Sleep Habits Linked to Brain AgingCEFR A2

23 Jun 2026

Level A2 – High beginner / Elementary
3 min
141 words

A new study looked for links between common sleep habits and signs of brain aging. Researchers used existing brain scans and questionnaire answers from more than 23,000 middle-aged and older adults. Teams at two universities worked on the study.

Participants completed a baseline questionnaire from 2006 to 2010 about five sleep behaviors: sleep duration, daytime napping, sleeplessness, unintentional daytime dozing and snoring. About nine years later the same people had brain MRI scans. The scans measured white matter lesion volumes, which are areas of brain damage linked to higher dementia risk.

All five sleep behaviors were first linked to more lesion volume. After researchers adjusted for blood vessel health and lifestyle, three behaviors stayed clearly linked: sleeping outside seven-to-nine hours, frequent daytime napping and sleeplessness. The authors say improving sleep may help lower brain aging and dementia risk.

Difficult words

  • baselinefirst data or measurement in a study
  • lesionarea of damaged tissue in the body
  • white matterpart of the brain with many nerve fibers
  • adjustchange results to account for other factors
    adjusted
  • dementiamedical condition affecting memory and thinking
  • sleeplessnessdifficulty sleeping or not sleeping enough
  • napshort sleep during the day
    napping

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Do you nap during the day? Why or why not?
  • How many hours do you usually sleep each night?
  • Have you ever had trouble sleeping? What do you do then?

Related articles

Tofersen slows a rare form of ALS (Level A2)
26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.